CanadaBis Capital Inc
OTC:CNADF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (1.8), the stock would be worth $0.03 (39% upside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.3 | $0.02 |
0%
|
| 3-Year Average | 1.8 | $0.03 |
+39%
|
| 5-Year Average | 2 | $0.03 |
+55%
|
| Industry Average | 3.2 | $0.05 |
+144%
|
| Country Average | 6.6 | $0.1 |
+413%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
C
|
CanadaBis Capital Inc
OTC:CNADF
|
2.1m USD | 1.3 | -1.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883B USD | 16.9 | 42.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.5B USD | 8.8 | 26.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 6.3 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.3B GBP | 6.4 | 28 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
270.2B USD | 5.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
216.3B CHF | 7.4 | 20.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 160.7 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 5.2 | 11.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.8B USD | 4.2 | 19.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 4.4 | 17.3 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 3.8 |
| Median | 6.6 |
| 70th Percentile | 10.6 |
| Max | 259 067.6 |
Other Multiples
CanadaBis Capital Inc
Glance View
CanadaBis Capital Inc. is a capital pool company, which engages in the identification and evaluation of assets or a business. The company is headquartered in Rocky Mountain House, Alberta. The company went IPO on 2017-03-08. The Company’s segments include Wholesale, Retail, and Extraction and Tolling. The Wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards that are subsequently sold to end consumers. The Retail segment involves in the sale of cannabis and cannabis-related products to end consumers on premise owned and operated by the Company. The Extraction and Tolling segment provides cannabinoid extraction services to other licensed producers. The Company’s subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd, Full Spectrum Labs Ltd, 2103157 Alberta Ltd. and Goldstream Cannabis Inc.
